Literature DB >> 15470897

Method for enhancing solubility of the expressed recombinant proteins in Escherichia coli.

Sudip Ghosh1, Sheeba Rasheedi, Sheikh Showkat Rahim, Sharmistha Banerjee, Rakesh Kumar Choudhary, Prachee Chakhaiyar, Nasreen Z Ehtesham, Sangita Mukhopadhyay, Seyed E Hasnain.   

Abstract

The production of correctly folded protein in Escherichia coli is often challenging because of aggregation of the overexpressed protein into inclusion bodies. Although a number of general and protein-specific techniques are available, their effectiveness varies widely. We report a novel method for enhancing the solubility of overexpressed proteins. Presence of a dipeptide, glycylglycine, in the range of 100 mM to 1 M in the medium was found to significantly enhance the solubility (up to 170-fold) of the expressed proteins. The method has been validated using mycobacterial proteins, resulting in improved solubilization, which were otherwise difficult to express as soluble proteins in E. coli. This method can also be used to enhance the solubility of other heterologous recombinant proteins expressed in a bacterial system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470897     DOI: 10.2144/04373ST07

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  13 in total

Review 1.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

2.  The human hGSTA5 gene encodes an enzymatically active protein.

Authors:  Sharda P Singh; Ludwika Zimniak; Piotr Zimniak
Journal:  Biochim Biophys Acta       Date:  2009-08-04

3.  Characterization of Anaplasma phagocytophilum major surface protein 5 and the extent of its cross-reactivity with A. marginale.

Authors:  N I Strik; A R Alleman; A F Barbet; H L Sorenson; H L Wamsley; F P Gaschen; N Luckschander; S Wong; F Chu; J E Foley; A Bjoersdorff; S Stuen; D P Knowles
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

4.  Optimization of soluble human interferon-γ production in Escherichia coli using SUMO fusion partner.

Authors:  Fenfen Zhu; Qi Wang; Hefang Pu; Shasha Gu; Lan Luo; Zhimin Yin
Journal:  World J Microbiol Biotechnol       Date:  2012-10-06       Impact factor: 3.312

5.  Metabolic engineering of a Lactobacillus plantarum double ldh knockout strain for enhanced ethanol production.

Authors:  Siqing Liu; Nancy N Nichols; Bruce S Dien; Michael A Cotta
Journal:  J Ind Microbiol Biotechnol       Date:  2005-09-29       Impact factor: 3.346

6.  Iron-dependent RNA-binding activity of Mycobacterium tuberculosis aconitase.

Authors:  Sharmistha Banerjee; Ashok Kumar Nandyala; Podili Raviprasad; Niyaz Ahmed; Seyed E Hasnain
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

7.  DNA clasping by mycobacterial HU: the C-terminal region of HupB mediates increased specificity of DNA binding.

Authors:  Sandeep Kumar; Abhijit A Sardesai; Debashree Basu; Kalappagowda Muniyappa; Seyed E Hasnain
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

8.  Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli.

Authors:  Kamal Veisi; Safar Farajnia; Nosratollah Zarghami; Hamid Reza Khoram Khorshid; Nasser Samadi; Shiva Ahdi Khosroshahi; Hossein Zarei Jaliani
Journal:  Adv Pharm Bull       Date:  2015-12-31

9.  Caffeine junkie: an unprecedented glutathione S-transferase-dependent oxygenase required for caffeine degradation by Pseudomonas putida CBB5.

Authors:  Ryan M Summers; Jennifer L Seffernick; Erik M Quandt; Chi Li Yu; Jeffrey E Barrick; Mani V Subramanian
Journal:  J Bacteriol       Date:  2013-09       Impact factor: 3.490

10.  In-vitro helix opening of M. tuberculosis oriC by DnaA occurs at precise location and is inhibited by IciA like protein.

Authors:  Sandeep Kumar; Aisha Farhana; Seyed E Hasnain
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.